KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Receivables (2016 - 2025)

Historic Receivables for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $472.5 million.

  • Bio-Rad Laboratories' Receivables rose 148.2% to $472.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $472.5 million, marking a year-over-year increase of 148.2%. This contributed to the annual value of $472.5 million for FY2025, which is 148.2% up from last year.
  • Bio-Rad Laboratories' Receivables amounted to $472.5 million in Q4 2025, which was up 148.2% from $474.2 million recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Receivables ranged from a high of $513.1 million in Q1 2023 and a low of $401.2 million during Q2 2021
  • Moreover, its 5-year median value for Receivables was $467.1 million (2023), whereas its average is $461.5 million.
  • As far as peak fluctuations go, Bio-Rad Laboratories' Receivables skyrocketed by 1891.03% in 2022, and later tumbled by 1042.03% in 2024.
  • Bio-Rad Laboratories' Receivables (Quarter) stood at $425.7 million in 2021, then grew by 18.91% to $506.2 million in 2022, then dropped by 1.06% to $500.9 million in 2023, then decreased by 7.05% to $465.6 million in 2024, then increased by 1.48% to $472.5 million in 2025.
  • Its Receivables was $472.5 million in Q4 2025, compared to $474.2 million in Q3 2025 and $478.0 million in Q2 2025.